Ochs Matthias, Schüttler Markus, Stichtenoth Guido, Herting Egbert
Institute of Anatomy, Experimental Morphology, University of Bern, Baltzerstrasse 2, CH-3012 Bern, Switzerland.
Respir Res. 2006 Jun 6;7(1):86. doi: 10.1186/1465-9921-7-86.
Surfactant dysfunction due to inhibition is involved in the pathophysiology of meconium aspiration syndrome. Dextran addition has been shown to reverse exogenous surfactant inactivation by meconium, but the precise mechanisms and the morphological correlate of this effect are yet unknown. Morphological surfactant analysis by transmission electron microscopy (TEM) and stereology allows the differentiation of active (large aggregates = LA) and inactive (small aggregates = SA) subtypes.
To determine the in vitro effects of meconium and dextran addition on the morphology of a modified porcine natural surfactant (Curosurf), Curosurf samples were either incubated alone or together with meconium or with meconium and dextran, fixed and processed for TEM. Volume fractions of surfactant subtypes [lamellar body-like forms (LBL), multilamellar vesicles (MV), unilamellar vesicles (UV)] were determined stereologically.
All preparations contained LBL and MV (corresponding to LA) as well as UV (corresponding to SA). The volume fraction of UV increased with addition of meconium and decreased with further addition of dextran. Correspondingly, the UV/(LBL+MV) ratio (resembling the SA/LA ratio) increased when meconium was added and decreased when dextran was added to the surfactant-meconium mixture.
Meconium causes alterations in the ultrastructural composition of Curosurf that can be visualized and analyzed by TEM and stereology. These alterations resemble an increase in the SA/LA ratio and are paralleled by an increase in minimum surface tension. Dextran prevents these effects and may therefore be a useful additive to exogenous surfactant preparations to preserve their structural and functional integrity, thereby improving their resistance to inactivation.
抑制导致的表面活性剂功能障碍参与了胎粪吸入综合征的病理生理学过程。已表明添加右旋糖酐可逆转胎粪对外源性表面活性剂的失活作用,但这种效应的确切机制及其形态学关联尚不清楚。通过透射电子显微镜(TEM)和体视学进行的形态学表面活性剂分析可区分活性(大聚集体 = LA)和非活性(小聚集体 = SA)亚型。
为了确定胎粪和添加右旋糖酐对改良猪天然表面活性剂(珂立苏)形态的体外影响,将珂立苏样品单独孵育,或与胎粪一起孵育,或与胎粪和右旋糖酐一起孵育,固定后进行TEM处理。通过体视学确定表面活性剂亚型[板层小体样形式(LBL)、多层囊泡(MV)、单层囊泡(UV)]的体积分数。
所有制剂均含有LBL和MV(对应于LA)以及UV(对应于SA)。添加胎粪后UV的体积分数增加,进一步添加右旋糖酐后降低。相应地,当向表面活性剂 - 胎粪混合物中添加胎粪时,UV/(LBL + MV)比值(类似于SA/LA比值)增加,添加右旋糖酐时降低。
胎粪会导致珂立苏超微结构组成发生改变,可通过TEM和体视学进行观察和分析。这些改变类似于SA/LA比值增加,并伴有最小表面张力增加。右旋糖酐可防止这些效应,因此可能是外源性表面活性剂制剂的一种有用添加剂,可保持其结构和功能完整性,从而提高其抗失活能力。